Pacific Biosciences (PACB) Stock Price, Quote, News & History

Comments

Pacific Biosciences of California Inc (PACB) Stock Price, Quote, News & History

PACBNASDAQ

Trade with Public

$1.56

0.042.63%

At close: Mar 4, 4:00 PM EST

$1.57

0.01010.65%

After Hours: 7:46 PM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.57

Close

$1.56

Volume / Avg.

5.16M / 7.22M

Day Range

$1.55 - $1.65

52 Wk Range

0.85 - 2.73

Market Cap

$474.02M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

14.66%

Days to Cover

5.27

Recent Pacific Biosciences of California Inc News

Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks

The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 will be the year of the genomic revolution.

Erica Kollmann

Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Avi Kapoor

Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-122.79M

Investing Cash Flow (TTM)

147.66M

Financing Cash Flow (TTM)

-46.77M

Free Cash Flow (TTM)

-131.26M

Capital Expenditure (TTM)

-8.47M

Net Change in Cash (TTM)

-21.91M

Analyst Trends and Forecast

1

Nov 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$933.14M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.92

PB Ratio (TTM)

88.08

Earnings Yield % (TTM)

-116.67%

Earnings Yield % (FWD)

-33.11%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.02

Company Debt

Total Debt

$645.16M

LT Debt

$645.16M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$56.47M

Debt to Equity

19.40

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

$1.57

Close

$1.56

Volume / Avg.

5.16M / 7.22M

Day Range

$1.55 - $1.65

52 Wk Range

0.85 - 2.73

Market Cap

$474.02M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

14.66%

Days to Cover

5.27

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, res...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Pacific Biosciences (PACB) stock?

A

You can purchase shares of Pacific Biosciences (NASDAQ:PACB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Pacific Biosciences (PACB) competitors?

A

Other companies in Pacific Biosciences’s space includes: 10x Genomics Inc (NASDAQ:TXG), Codexis Inc (NASDAQ:CDXS), BioLife Solutions Inc (NASDAQ:BLFS), Lifecore Biomedical Inc (NASDAQ:LFCR) and Quanterix Corp (NASDAQ:QTRX).

Q

What is the forecast, or price target, for Pacific Biosciences (PACB) stock?

A

Pacific Biosciences has a consensus price target of $4.36.

Q

What is the current price for Pacific Biosciences (PACB)?

A

The stock price for Pacific Biosciences (NASDAQ: PACB) is $1.5701 last updated March 4, 2026 at 7:46 PM EST.

Q

Does Pacific Biosciences (PACB) pay a dividend?

A

There are no upcoming dividends for Pacific Biosciences.

Q

When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?

A

Pacific Biosciences does not have any upcoming earnings scheduled.

Q

Is Pacific Biosciences (PACB) going to split?

A

There is no upcoming split for Pacific Biosciences.

Q

What sector and industry does Pacific Biosciences (PACB) operate in?

A

Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch

BioLife Solutions Inc

NASDAQ:BLFS

$20.67

%

Lifecore Biomedical Inc

AbCellera Biologics Inc

NASDAQ:ABCL

$3.65

0.54%

Cytek Biosciences Inc

Key Statistics

Open

$1.57

Close

$1.56

Volume / Avg.

5.16M / 7.22M

Day Range

$1.55 - $1.65

52 Wk Range

0.85 - 2.73

Market Cap

$474.02M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

14.66%

Days to Cover

5.27

Recent Pacific Biosciences of California Inc News

Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks

The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 will be the year of the genomic revolution.

Erica Kollmann

Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Avi Kapoor

Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-122.79M

Investing Cash Flow (TTM)

147.66M

Financing Cash Flow (TTM)

-46.77M

Free Cash Flow (TTM)

-131.26M

Capital Expenditure (TTM)

-8.47M

Net Change in Cash (TTM)

-21.91M

Analyst Trends and Forecast

1

Nov 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$933.14M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.92

PB Ratio (TTM)

88.08

Earnings Yield % (TTM)

-116.67%

Earnings Yield % (FWD)

-33.11%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.02

Company Debt

Total Debt

$645.16M

LT Debt

$645.16M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$56.47M

Debt to Equity

19.40

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

$1.57

Close

$1.56

Volume / Avg.

5.16M / 7.22M

Day Range

$1.55 - $1.65

52 Wk Range

0.85 - 2.73

Market Cap

$474.02M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

14.66%

Days to Cover

5.27

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, res...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry